I wish they would drop the drug side all together. It's too expensive and most drugs fail to get FDA approval.
Hope they wake up to that fact and stick with expanding a very profitable company. If they were smart they would share the patent rights with a big pharma company and let them run the clinical trials. If the drug gets FDA approval then the profits are shared. Zero additional out of pocket expenses and lots of money our way to our bottom line.
That is my hope. Instead the reality is they will have to take out big loans (debt) and there goes profits.
Market Data 
Markets 
AI
